Results 81 to 90 of about 199,605 (258)

Therapeutic Potential of Vasopressin-Receptor Antagonists in Heart Failure

open access: yesJournal of Pharmacological Sciences, 2014
.: Arginine vasopressin (AVP) is a 9-amino acid peptide that is secreted from the posterior pituitary in response to high plasma osmolality and hypotension.
Yasukatsu Izumi   +2 more
doaj  

New Topics in Vasopressin Receptors and Approach to Novel Drugs: Involvement of Vasopressin V1a and V1b Receptors in Nociceptive Responses and Morphine-Induced Effects

open access: yesJournal of Pharmacological Sciences, 2009
Arginine vasopressin (AVP) receptors have been classified into V1a, V1b, and V2 subtypes. Recent studies have demonstrated the involvement of AVP in anti-nociception and in morphine-induced anti-nociception.
Kenji Honda, Yukio Takano
doaj  

Increased Plasma Arginine Vasopressin in Clinical Adrenocortical Insufficiency and Its Inhibition By Glucosteroids* [PDF]

open access: bronze, 1967
Abdul Barik Ahmed   +3 more
openalex   +1 more source

Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.

open access: yesJournal of Clinical Investigation, 1973
A radioimmunoassay has been developed that permits reliable measurements of plasma arginine vasopressin (AVP) at concentrations as low as 0.5 pg/ml in sample volumes of 1 ml or less.
G. Robertson   +3 more
semanticscholar   +1 more source

Copeptin in heart failure

open access: yesResearch Reports in Clinical Cardiology, 2014
Bartosz Lasota,1 Katarzyna Mizia-Stec212nd Department of Cardiology, Medical University of Silesia, Katowice, Poland; 21st Department of Cardiology, Medical University of Silesia, Katowice, PolandAbstract: Copeptin is a novel indicator of arginine&ndash ...
Lasota B, Mizia-Stec K
doaj  

54: Arginine-Vasopressin (AVP) secretion and placental transfer in maternal (M) and foetal (F) sheep [PDF]

open access: hybrid, 1976
P Czernichow   +4 more
openalex   +1 more source

New Topics in Vasopressin Receptors and Approach to Novel Drugs: Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia

open access: yesJournal of Pharmacological Sciences, 2009
Hyponatremia is the most common electrolyte disorder in hospitalized patients and is associated with the risk of intractable seizures and death. The effectiveness of conventional therapies for hyponatremia is inconsistent, and the rapid correction of ...
Yukinori Arai   +3 more
doaj  

Home - About - Disclaimer - Privacy